Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerOpenAI sign Language
VIPCreated with Sketch.

Supplemental figure 3 from A Multicenter, Open-Label Phase II Clinical Trial of Combined MEK plus EGFR Inhibition for Chemotherapy-Refractory Advanced Pancreatic Adenocarcinoma

Andrew H. Ko, Tanios Bekaii-Saab,Jessica Van Ziffle,Olga M. Mirzoeva, Nancy M. Joseph,AmirAli Talasaz,Peter Kuhn,Margaret A. Tempero,Eric A. Collisson, R. Kate Kelley, Alan P. Venook, Elizabeth Dito,Anna Ong,Sharvina Ziyeh,Ryan Courtin,Regina Linetskaya,Sanaa Tahiri,W. Michael Korn

crossref（2023）

Cited 0|Views0
No score
Abstract
Supplemental figure 3. Mutation frequencies in pre-and on-treatment plasma samples as determined by next-generation sequencing of cfDNA using the Guardant360 assay.
More
Translated text
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined